Showing results (591-600 of 2,000) with videos related to
Sort By:
Pageof 200
Journal of Clinical Lipidology|December 31, 2021
Clinical, genetic profile and therapy evaluation of 55 children and 5 adults with sitosterolemiaYu Xia, Ying Duan, Wanqi Zheng, et al.Journal of Clinical Lipidology|October 9, 2022
Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemiaDaniel Gaudet, Andrea Ruzza, Ian Bridges, et al.Journal of Clinical Lipidology|September 6, 2022
GPIHBP1 autoantibody is an independent risk factor for the recurrence of hypertriglyceridemia-induced acute pancreatitisGuofu Zhang, Qi Yang, Wenjian Mao, et al.Journal of Clinical Lipidology|February 22, 2021
C3 and alternative pathway components are associated with an adverse lipoprotein subclass profile: The CODAM studyYing Xin, Elisabeth Hertle, Carla J H van der Kallen, et al.Journal of Clinical Lipidology|September 24, 2022
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromesPatrick M Moriarty, Philippe Gabriel Steg, Jennifer McGinniss, et al.Journal of Clinical Lipidology|September 24, 2022
Cholesterol mass efflux capacity and coronary artery calcium: The Multi-Ethnic Study of AtherosclerosisParveen K Garg, William Tressel, Robyn L McClelland, et al.Journal of Clinical Lipidology|May 24, 2011
Clinical perspective: have the results of recent clinical trials of lipid-lowering therapies influenced the way we should practice? A Latin American perspective of current issues in clinical lipidologyRaul D Santos, Alberto J Lorenzatti, Carlos Fernandez Barros, et al.Journal of Clinical Lipidology|May 24, 2011
The population effects of the global cardiovascular risk model in United States adults: findings from the National Health and Nutrition Surveys, 2005-2006Matthew C Tattersall, Kunal N Karmali, Ronald E Gangnon, et al.Journal of Clinical Lipidology|May 24, 2011
Influence of simvastatin, fenofibrate and/or ezetimibe on correlation of low-density lipoprotein and nonhigh-density lipoprotein cholesterol with apolipoprotein B in mixed dyslipidemic patientsMichel Farnier, William Taggart, Qian Dong, et al.Pageof 200